Skip to main content
PAS 2024 Meeting Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Pre-Conference Ticketed Event
Pre-Conference Ticketed Event
APA Award Winner
APA Award Winner
APS Award Winner
APS Award Winner
ASPN Award Winner
ASPN Award Winner
SPR Award Winner
SPR Award Winner
On Demand Presentation
On Demand Presentation
Poster Icons
SPR Award Winner
SPR Award Winner
Back
Evaluation ViewAttendees 70
Panel Discussion

Academic and Research Skills

Clinical Research

Diversity, Equity, and Inclusion
Session Type: Panel Discussion

The Changing Face of Neonatal Clinical Trials

Monday, May 6, 2024
8:00 AM – 9:30 AM ET
Location: Metro Toronto Convention Centre: 105
CE: Live CME: 1.5

Selected By: SPR
Co-sponsored By: Neonatal
Disclosure(s):
Carl H. Backes, MD, Jr.: Abbott (Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator)
Susan R. Hintz, MD, MS: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Session

Description: Clinical trials are the best vehicle for turning medical information that we think is true into evidence that we know, within reasonable limits, to be true. The session herein will explore challenges and opportunities in the performance of contemporary neonatal clinical trials. Insights will be provided from trialists, using real-world examples, to optimize trial efficiency and conduct. To accelerate progress, the symposium will highlight new and innovative strategies to optimize recruitment and overcome barriers (issues with equipoise, strong patient preferences) to trial conduct. To synergize the efforts of many partners, the symposium will outline the value of partnerships with families and nurses in study design and execution. The symposium will emphasize the value of inclusive, diverse, and multidisciplinary approaches to neonatal clinical trials.

Learning Objectives:

  • Understand innovative approaches to neonatal trial recruitment and retention, prioritize endpoints meaningful to families, and recognize the utility of telemedicine for longitudinal outcomes assessment.
  • Understand a "team science" approach leveraging a multidisciplinary health care team and families, including a review of strategies to increase trial participation among underrepresented minorities.
  • Understand the value of formal economic evaluations alongside clinical trials to support the practice of effective and efficient health care.

Presentations:

  • 8:00 AM – 8:05 AM ET
    Welcome and Introduction

    Speaker: Carl H. Backes, Jr., MD (he/him/his) – Nationwide Children's Hospital

  • 8:05 AM – 8:15 AM ET
    QuinteT Recruitment Intervention (QRI) increases enrollment in adult trials; why have we not accepted QRI in neonatology?

    Speaker: Louise Davies, MD, MS (she/her/hers) – Dartmouth College

  • 8:15 AM – 8:25 AM ET
    Increasing trial participation among underrepresented minorities.

    Speaker: Andrea F. Duncan, MD. MSCR (she/her/hers) – University of Pennsylvania and Children's Hospital of Philadelphia

  • 8:25 AM – 8:35 AM ET
    Best practices regarding consent processes: avoiding the “one size fits all” approach.

    Speaker: Elizabeth Foglia, MD, MSCE (she/her/hers) – Childrens Hospital of Philadelphia

  • 8:35 AM – 8:45 AM ET
    Choosing outcomes meaningful to families: the parental perspective.

    Speaker: Annie Janvier, MD, PhD (Annie) – Université de Montréal, CHU Sainte-Justine

  • 9:15 AM – 9:25 AM ET
    A path forward: Re-imagining neonatal clinic trials + Question and Answer Session

    Speaker: Susan R. Hintz, MD, MS (she/her/hers) – Stanford University School of Medicine